Author name: DrugChatter

There’s a certain point in every drug’s life cycle when patients stop asking what does this do? and start asking […]

The hidden panic behind America’s fastest-growing drug questions There’s a particular tone that shows up in pharmaceutical search behavior once

ChatGPT, Gemini, and Claude now field millions of drug-safety questions every day. None of them have a medical license. Here’s

Somewhere right now, a patient is asking ChatGPT whether their cancer drug will extend their life. A caregiver is asking

For the better part of three decades, pharmaceutical companies have monitored what the world says about their drugs through the

There’s a certain phase every drug eventually enters once it escapes the controlled environment of clinical trials and lands in

Inside the internet’s endless search for “Can I take this every day forever?” There’s a particular kind of pharmaceutical question

A parent in Texas asks ChatGPT how much ibuprofen to give her 18-month-old. ChatGPT returns a dose calculated for a

The shift happened without a product launch, without a press release, and without a single pharmaceutical company authorizing it. Sometime

There’s a revealing pattern hidden inside patient search behavior. It’s not the ultra-rare oncology agents or impossible-to-pronounce biologics generating the

Walk into any pharmaceutical compliance team’s weekly meeting and you’ll find the same agenda items from the past decade: OPDP

How drug brands fought off-label prescribing to survive: real FDA cases, litigation wins, and what AI monitoring means for pharmacovigilance